SEI Investments’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

SEI Investments’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,752	Closed	-$282K	–	2773
2022 Q2	$282K	Buy	+3,752	New	+$167K	﹤0.01%	2350
2022 Q1	–	Sell	-9,958	Closed	-$475K	–	2694
2021 Q4	$475K	Sell	9,958 -5,561	-36%	-$249K	﹤0.01%	2126
2021 Q3	$1.03M	Buy	15,519 +12	+0.1%	+$855	﹤0.01%	1773
2021 Q2	$1.21M	Sell	15,507 -306	-2%	-$22.6K	﹤0.01%	1734
2021 Q1	$1.66M	Sell	15,813 -367	-2%	-$43.6K	﹤0.01%	1533
2020 Q4	$1.97M	Sell	16,180 -1,058	-6%	-$116K	0.01%	1400
2020 Q3	$1.51M	Buy	17,238 +13,233	+330%	+$922K	﹤0.01%	1422
2020 Q2	$259K	Buy	+4,005	New	+$231K	﹤0.01%	2140
2019 Q4	–	Sell	-9,199	Closed	-$346K	–	2469
2019 Q3	$346K	Buy	+9,199	New	+$400K	﹤0.01%	2058

SEI Investments's TPTX Position: Q3 2022 in Review

SEI Investments sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 3,752 shares — an estimated $282K sold.

SEI Investments first reported a position in TPTX in Q3 2019 and held it in 9 quarters. The position peaked at $1.97M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

SEI Investments reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
SEI Investments sold 3,752 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $282K.
SEI Investments first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 9 quarters.
SEI Investments's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.97M in Q4 2020.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on SEI Investments's 13F filing for Q3 2022, filed 14 Nov 2022.